Laminin subunit beta-4 (LAMB4)

Laminin subunit beta-4 (LAMB4) is a protein coding gene that encodes one of the beta chains of laminins, which are large, heterotrimeric glycoproteins critical for the structure and function of basement membranes in animal tissues[2][1]. Laminins, composed of α, β, and γ chains, provide vital scaffolding for cell support and are necessary for tissue morphogenesis and stability[1]. LAMB4 is predominantly expressed in the myenteric plexus of the colon and is involved in the organization of the extracellular matrix and regulation of the enteric nervous system[2]. Rare variants in LAMB4 are linked to altered colonic innervation and may contribute to disorders such as diverticulitis[2]. LAMB4 does not have a recognized role as a direct therapeutic target or known small molecule ligand, nor is it classified as a typical receptor, enzyme, or transporter in current biomedical research[2][1][3]. Specific notes: - There is some ambiguity and confusion in the literature, as LAMB4 is a distinct protein from laminin subunit beta-4 (sometimes LAMB4 is confused with LAMB2 or the closely related LAMB3/LAMC2 of the hemidesmosome complex). LAMB4 is not the well-characterized Laminin beta-4 (LAMB4) receptor found in the skin and kidney (that is actually LAMB3 paired with LAMA3/LAMC2 as laminin-332). - LAMB4 is not currently considered a primary drug target in pharmacology and lacks relevant interacting drugs, mechanisms of drug action, or established biomarker status. - Several references describe its genetic association with familial colon disease and possible implications in colon cancer but not as a routine clinical biomarker or therapeutic target[2]. In summary, Laminin subunit beta-4 (LAMB4) is a structural extracellular matrix protein implicated in tissue maintenance and specific disease associations, but it is not presently a canonical therapeutic target, receptor, or enzyme.

Other names

Laminin beta-1-related proteinlaminin β4laminin subunit beta-4LAMB4